For example, there has been only one drug approved by US Food and Drug Administration (FDA) for treating ischemic stroke—Recombinant Tissue-Type Plasminogen Activator (r-tPA), which was approved by FDA in 1996 (Marko et al. 2020; Zivin 2009). This evidence concerns the gene PLAT and ischemic stroke.